World Health Organization, https://www.who.int/malaria/media/world-malaria-report-2018/en/ (accessed Jan 21, 2021).

World Health Organization, https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2021 (accessed Oct 02, 2022).

R. Killick-Kendrick, Rodent malaria, Elsevier Science, London, England, 2014, p 1-52. ISBN 0124071503

A.G. Craig, G.E. Grau, C. Janse, J.W. Kazura, D. Milner, J.W. Barnwell, G. Turner, and J. Langhorne. The role of animal models for research on severe malaria. PLoS Pathogen 8 (2012) e1002401. https://doi.org/10.1371/journal.ppat.1002401.

K. Plewes, S. J. Leopold, H.W.F. Kingston, A.M. Dondorp. Malaria: What’s new in the management of malaria? Infectious. Disease Clinics of North American 33 (2019) 39-60. https://doi.org/10.1016/j.idc.2018.10.002.

L.L. Gustafsson, Handbook of drugs for tropical parasitic infections, Taylor & Francis, London, England, 1995. ISBN 0748401687

DrugBank online, https://www.drugbank.ca/drugs/DB00608 (accessed Jan 21, 2021).

P.G Bray, O. Janneh, K.J. Raynes, M. Mungthin, H. Ginsburg, S.A. Ward. Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum. Journal of Cell Biology 145 (1999) 363-376. https://doi.org/10.1083/jcb.145.2.363.

M. Chinappi, A. Via, P. Marcatili, A. Tramontano. On the mechanism of chloroquine resistance in Plasmodium falciparum. PLoS One 5 (2010) e14064. https://doi.org/10.1371/journal.pone.0014064.

G.N.L. Galappaththy, P. Tharyan, R. Kirubakaran. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine. Cochrane Database of Systematic Reviews 10 (2013) CD004389. https://doi.org/10.1002/14651858.CD004389.pub3.

C.V. Plowe, C. Roper, J.W. Barnwell, C.T. Happi, H.H. Joshi, W. Mbacham, S.R. Meshnick, K. Mugittu, I. Naidoo, R. N. Price, R. W. Shafer, C. H. Sibley, C. J. Sutherland, P. A. Zimmerman, P. J. Rosenthal. World antimalarial resistance network (WARN) III: Molecular markers for drug resistant malaria. Malaria Journal 6 (2007) 121. https://doi.org/10.1186/1475-2875-6-121.

A.N. El-Shorbagi. New tetrahydro-2H-1,3,5-thiadiazine-2-thione derivatives as potential antimicrobial agents. Archive der Pharmazie 333 (2000) 281-286. https://doi.org/10.1002/1521-4184(20009)333:9<281::aid-ardp281>3.0.co;2-e.

J. Coro, R. Pérez, H. Rodríguez, M. Suárez, C. Vega, M. Rolón, D. Montero, J.J. Nogal, A. Gomez-Barrio. Synthesis and antiprotozoan evaluation of new alkyl-linked bis(2-thioxo-[1,3,5]thiadiazinan-3-yl) carboxylic acids. Bioorganicand Medicinal Chemistry 13 (2005) 3413-3421. https://doi.org/10.1016/j.bmc.2005.03.009.

J. Coro, R. Pérez, L. Monzote, H. Rodríguez, M. Suárez. Thiadiazine derivatives as antiprotozoal new drugs. The open medicinal chemistry journal 5 (2011) 51-60. https://doi.org/10.2174/1874104501105010051.

J. Coro, R. Atherton, S. Little, H. Wharton, V. Yardley, A. Alvarez A, M. Suárez, R. Pérez, H. Rodriguez. Alkyl-linked bis-thtt derivatives as potent in vitro trypanocidal agents. Bioorganic and Medicinal Chemistry Letters 16 (2006) 1312-1315. https://doi.org/10.1016/j.bmcl.2005.11.060.

J. Coro, S. Little, V. Yardley, M. Suárez, H. Rodríguez, N. Martín, R. Perez-Piñeiro. Synthesis and antiprotozoal evaluation of new n4-(benzyl)spermidyl-linked bis(1,3,5-thiadiazinane-2-thiones). Archive del Pharmazie 341 (2008) 708-713. https://doi.org/10.1002/ardp.200800011.

B.R. Moore, M. Page-Sharp, J.R. Stoney, K.F. Ilett, J.D. Jago, K.T. Batty. Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model. Antimicrobial Agents and Chemotherapy 55 (2011) 3899-3907. https://doi.org/10.1128/AAC.00067-11.

C.F. Brayton. Dimethyl sulfoxide (DMSO): A review. The Cornell Veterinarian 76 (1986) 61-90. https://pubmed.ncbi.nlm.nih.gov/3510103/

L.M. Spencer-Valero, S.A. Ogun, S.L. Fleck, I.T. Ling, T.J. Scott-Finnigan, M.J. Blackman, A.A. Holder. Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein 1 suppresses parasitemia. Infection and Immunity 66 (1998) 3925-3930. https://doi.org/10.1128/IAI.66.8.3925-3930.1998.

K. Moll, A. Kaneko, A. Scherf, M. Wahlgren. Methods in malaria research; EviMalar, 6th ed. Glasgow, U.K., 2013, 1-499. https://www.beiresources.org/portals/2/MR4/Methods_In_Malaria_Research-6th_edition.pdf (accessed Jan 21, 2021).

A. Voller, D.E. Bidwell, A. Bartlett. Enzyme immunoassays in diagnostic medicine. theory and practice. Bulletin of the World Health Organization 53 (1976) 55-65. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2366417/

A. Voller, D. Bidwell. Enzyme-linked immunosorbent assay. Manual of clinical immunology, 3rd edn. American Society for Microbiology, Washington DC, United States of America, 1986, 99-109.

Promega Corporation, https://www.promega.es/products/cell-health-assays/cell-viability-and-cytotoxicity-assays/celltiter-96-aqueous-one-solution-cell-proliferation-assay-_mts_/?catNum=G3582 (accessed Jan 21, 2021).

I. Abrahasem, J.B. Lorens. Evaluating extracellular matrix influence on adherent cell signaling by cold trypsin phosphorylation-specific flow cytometry. BMC Molecular and Cell Biology 19 (2013) 14-36. https://doi.org/10.1186/1471-2121-14-36.